146 related articles for article (PubMed ID: 25463482)
21. Lysophosphatidic Acid Receptor 3 (LPA3): Signaling and Phosphorylation Sites.
Solís KH; Romero-Ávila MT; Rincón-Heredia R; García-Sáinz JA
Int J Mol Sci; 2024 Jun; 25(12):. PubMed ID: 38928196
[TBL] [Abstract][Full Text] [Related]
22. LPA receptor 2 mediates LPA-induced endometrial cancer invasion.
Hope JM; Wang FQ; Whyte JS; Ariztia EV; Abdalla W; Long K; Fishman DA
Gynecol Oncol; 2009 Jan; 112(1):215-23. PubMed ID: 19019417
[TBL] [Abstract][Full Text] [Related]
23. LPA2 receptor mediates mitogenic signals in human colon cancer cells.
Yun CC; Sun H; Wang D; Rusovici R; Castleberry A; Hall RA; Shim H
Am J Physiol Cell Physiol; 2005 Jul; 289(1):C2-11. PubMed ID: 15728708
[TBL] [Abstract][Full Text] [Related]
24. Suppression of EDAG gene expression by phorbol 12-myristate 13-acetate is mediated through down-regulation of GATA-1.
Li CY; Fang F; Xu WX; Xu CW; Zhan YQ; Wang ZD; Ding YL; Li YH; Sun HB; Yang XM
Biochim Biophys Acta; 2008 Oct; 1779(10):606-15. PubMed ID: 18599389
[TBL] [Abstract][Full Text] [Related]
25. Specific LPA receptor subtype mediation of LPA-induced hypertrophy of cardiac myocytes and involvement of Akt and NFkappaB signal pathways.
Chen J; Chen Y; Zhu W; Han Y; Han B; Xu R; Deng L; Cai Y; Cong X; Yang Y; Hu S; Chen X
J Cell Biochem; 2008 Apr; 103(6):1718-31. PubMed ID: 17891781
[TBL] [Abstract][Full Text] [Related]
26. Vascular smooth muscle migration and proliferation in response to lysophosphatidic acid (LPA) is mediated by LPA receptors coupling to Gq.
Kim J; Keys JR; Eckhart AD
Cell Signal; 2006 Oct; 18(10):1695-701. PubMed ID: 16504475
[TBL] [Abstract][Full Text] [Related]
27. Synergistic effect of hydrogen peroxide on polyploidization during the megakaryocytic differentiation of K562 leukemia cells by PMA.
Ojima Y; Duncan MT; Nurhayati RW; Taya M; Miller WM
Exp Cell Res; 2013 Aug; 319(14):2205-15. PubMed ID: 23770036
[TBL] [Abstract][Full Text] [Related]
28. A screen for Fli-1 transcriptional modulators identifies PKC agonists that induce erythroid to megakaryocytic differentiation and suppress leukemogenesis.
Liu T; Yao Y; Zhang G; Wang Y; Deng B; Song J; Li X; Han F; Xiao X; Yang J; Xia L; Li YJ; Plachynta M; Zhang M; Yan C; Mu S; Luo H; Zacksenhaus E; Hao X; Ben-David Y
Oncotarget; 2017 Mar; 8(10):16728-16743. PubMed ID: 28052010
[TBL] [Abstract][Full Text] [Related]
29. Expressions of lysophosphatidic acid receptors in the development of human ovarian carcinoma.
Si J; Su Y; Wang Y; Yan YL; Tang YL
Int J Clin Exp Med; 2015; 8(10):17880-90. PubMed ID: 26770382
[TBL] [Abstract][Full Text] [Related]
30. A549 cells as a model to study endogenous LPA
Carmona-Rosas G; Alfonzo-Méndez MA; Hernández-Espinosa DA; Romero-Ávila MT; García-Sáinz JA
Eur J Pharmacol; 2017 Nov; 815():258-265. PubMed ID: 28943105
[TBL] [Abstract][Full Text] [Related]
31. Pim-1 induced polyploidy but did not affect megakaryocytic differentiation of K562 cells and CD34+ cells from cord blood.
Jung YJ; Chae HC; Seoh JY; Ryu KH; Park HK; Kim YJ; Woo SY
Eur J Haematol; 2007 Feb; 78(2):131-8. PubMed ID: 17313559
[TBL] [Abstract][Full Text] [Related]
32. GPR92/LPA₅ lysophosphatidate receptor mediates megakaryocytic cell shape change induced by human atherosclerotic plaques.
Khandoga AL; Pandey D; Welsch U; Brandl R; Siess W
Cardiovasc Res; 2011 Apr; 90(1):157-64. PubMed ID: 21106562
[TBL] [Abstract][Full Text] [Related]
33. RAFTK/Pyk2 mediates LPA-induced PC12 cell migration.
Park SY; Schinkmann KA; Avraham S
Cell Signal; 2006 Jul; 18(7):1063-71. PubMed ID: 16199135
[TBL] [Abstract][Full Text] [Related]
34. CDDO-Im is a stimulator of megakaryocytic differentiation.
Petronelli A; Pelosi E; Santoro S; Saulle E; Cerio AM; Mariani G; Labbaye C; Testa U
Leuk Res; 2011 Apr; 35(4):534-44. PubMed ID: 21035854
[TBL] [Abstract][Full Text] [Related]
35. Lysophosphatidic acid induces erythropoiesis through activating lysophosphatidic acid receptor 3.
Chiang CL; Chen SS; Lee SJ; Tsao KC; Chu PL; Wen CH; Hwang SM; Yao CL; Lee H
Stem Cells; 2011 Nov; 29(11):1763-73. PubMed ID: 21915944
[TBL] [Abstract][Full Text] [Related]
36. Lysophosphatidic acid mediates interleukin-8 expression in human endometrial stromal cells through its receptor and nuclear factor-kappaB-dependent pathway: a possible role in angiogenesis of endometrium and placenta.
Chen SU; Lee H; Chang DY; Chou CH; Chang CY; Chao KH; Lin CW; Yang YS
Endocrinology; 2008 Nov; 149(11):5888-96. PubMed ID: 18617617
[TBL] [Abstract][Full Text] [Related]
37. Ki16425, a subtype-selective antagonist for EDG-family lysophosphatidic acid receptors.
Ohta H; Sato K; Murata N; Damirin A; Malchinkhuu E; Kon J; Kimura T; Tobo M; Yamazaki Y; Watanabe T; Yagi M; Sato M; Suzuki R; Murooka H; Sakai T; Nishitoba T; Im DS; Nochi H; Tamoto K; Tomura H; Okajima F
Mol Pharmacol; 2003 Oct; 64(4):994-1005. PubMed ID: 14500756
[TBL] [Abstract][Full Text] [Related]
38. Reciprocal regulation of miR-23a and lysophosphatidic acid receptor signaling in cardiomyocyte hypertrophy.
Yang J; Nie Y; Wang F; Hou J; Cong X; Hu S; Chen X
Biochim Biophys Acta; 2013 Aug; 1831(8):1386-94. PubMed ID: 23711961
[TBL] [Abstract][Full Text] [Related]
39. Antidepressants activate the lysophosphatidic acid receptor LPA(1) to induce insulin-like growth factor-I receptor transactivation, stimulation of ERK1/2 signaling and cell proliferation in CHO-K1 fibroblasts.
Olianas MC; Dedoni S; Onali P
Biochem Pharmacol; 2015 Jun; 95(4):311-23. PubMed ID: 25888927
[TBL] [Abstract][Full Text] [Related]
40. Dual mode regulation of migration by lysophosphatidic acid in human gastric cancer cells.
Shida D; Kitayama J; Yamaguchi H; Hama K; Aoki J; Arai H; Yamashita H; Mori K; Sako A; Konishi T; Watanabe T; Sakai T; Suzuki R; Ohta H; Takuwa Y; Nagawa H
Exp Cell Res; 2004 Dec; 301(2):168-78. PubMed ID: 15530853
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
